Tuesday, September 21, 2010

Tuesday Tasting Menu 9-21-10

Salmon!
This week we wanted to bring you fresh, wild Alaskan Steelhead Salmon for our Tuesday chef's menu, in part because it's so wonderful, and in part so we could talk to you about our great concerns about the genetically engineered salmon that is in the process of being reviewed for approval by the FDA as the first genetically modified food animal. Read more about it later in this email.

The cost for the three course meal is $30 per person, with a paired wine flight for an additional $10. Learn more about the featured wines at the end of this email.
Courses are also available separately.
Reservations for Tuesday evening are highly recommended, and please tell us if you're planning on having the special 3-course menu so that we're sure to hold one for you.
Stan Godfriaux will be playing piano jazz in the bar.

Tuesday September 21, 2010
1st course
Salmon cake with corn salsa and fresh avocado with arugula salad

2nd course
Pan seared honey and citrus glazed salmon
with cilantro pesto Israeli couscous and caramelized shallot buerre blanc
(McWilliam's Hanwood Estate Chardonnay)
3rd course
Carmel honey cake with fresh strawberries
and citrus creme anglaise
(Croft Fine Ruby Port)
Courses also available separately

Genetically Engineered Salmon -
Hot Issue - Please read and help!

These are troubling times for wild salmon (and for all of us). This week the FDA was holding advisory panel meetings on approving the first genetically engineered food animal, an Atlantic salmon that has been genetically modified by AquaBounty with a gene from an eel-like fish called an ocean pout to keep a growth hormone permanently turned on.

Genetically Engineered SalmonThese genetically modified fish grow much more rapidly than the original salmon, and allow them to reach maturity in 16 to 18 months, rather than the standard 30 months.

We at Liliana's are quite concerned over the risks of this new modified fish. Even though the fish is intended to be raised in inland ponds, the risk that they could escape and threaten the native salmon populations is very troubling. The FDA doesn't really seem to be the correct agency to fully address the risks to the environment. And the assessment of the safety of the fish, in particular the possibility of aggravated allergic reactions, seems to be inadequate, with the expectation that they will learn more about the overall population sensitivity AFTER the fish has reached the market and they are able to do more extensive data collection.

Read more about the issue here, here, and here. Many, many consumer organizations have come out opposing the introduction of this fish into the market, including Consumer's Union.

It seems that approval is likely at this point, and the information on the FDA website seems to be already concluding that the fish is safe and should be approved. Although they discuss the written comments that they have received, it doesn't seem that they are really listening to them.

Join the conversation now and voice your concerns to your elected representatives.

No comments:

Post a Comment